At 3 months: HbA1c, kidney and liver function, lipids, and full blood count to assess early response and monitor for any emerging issues during the dose escalation phase
Understanding which patients are candidates for GLP-1RAs treatment will be key, according to Lorenzo Leggio, MD, PhD, clinical director of the National Institute on Drug Abuse
Longer treatment duration does not guarantee weight maintenance, but it may improve the chances of sustaining healthy behaviors once medication support is removed
The Method: Semaglutide Injection for Weight Loss The method of delivery for semaglutide is through injections, which are typically administered weekly
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
A product specifically designed for body contouring